
About Quick Heal
Quick Heal is a publicly listed company based in Pune (India) founded in 1995 by Kailash Katkar and Sanjay Katkar. Endpoint security is delivered via cloud-based antivirus software. The company has 977 employees. Quick Heal has completed 1 acquisition, including Junco Technologies. Quick Heal was last valued at $124.91 million in August 2010. Its chief executive, as recorded, is Kailash Katkar. Its website quickheal.co.in draws about 502 thousand monthly visits. Its Indian entity Quick Heal Technologies Limited reported revenue of βΉ284 Cr. Its focus areas include Enterprise Infrastructure, Cybersecurity, Endpoint Security and Anti Malware.
Company details
Quick Heal was founded in 1995 in Pune, India, within the cybersecurity sector. A cloud-based platform is operated to provide endpoint security through antivirus solutions for PCs, laptops, Macs, and Windows devices. Protection from cyber attacks and threats is ensured, supporting device performance and user security across operations.
- Headquarters Pune, India
- Employees 977
- Founders Kailash Katkar, Sanjay Katkar
- Stage Public
- SectorsTechnology
- Website category Computers Electronics and Technology · Search Engines
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website quickheal.co.in
- Social LinkedIn X Facebook
- Legal Name Quick Heal Technologies Ltd.
- Market Cap₹827 Cr
QUICKHEAL · NSE
- Share Price₹152.44
+0.67% today
- Revenue₹261 Cr
FY 2025-26 · -6.6% YoY
- EBITDA−₹29.37 Cr
Margin -11.2%
- Net Profit−₹16.76 Cr
FY 2025-26 · -709.5% YoY
- ROE-3.8%
ROCE -6.0%
- Latest Funding Round$8.27M (USD), Unspecified
Aug 2010
- InvestorsPeak XV Partners
& 1 more
- Employee Count977
- Investments & Acquisitions
Associated legal entities of Quick Heal
Quick Heal is associated with 2 registered companies on The Company Check; the primary company is Quick Heal Technologies Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Quick Heal Technologies Limited Listed CIN L72200MH1995PLC091408 | Active | 07 Aug 1995 | Pune, Maharashtra | ₹284 Cr | 1,027 | 8 | View details |
| Gagan Bharari Enterprises Llp CIN ACB-5397 | Active | 08 Jun 2023 | Pune, Maharashtra | 2 | View details |
Apps and channels of Quick Heal
Quick Heal publishes 1 mobile app with over 10M+ downloads.
Funding Insights of Quick Heal
- Total Rounds 1
- Last Round Unspecified β $8.27M
- First Round $8.27M
(Aug 2010)
- Investors Count 2
All 1 funding rounds of Quick Heal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2010 | $8.27M | Unspecified | $124.91M | Peak XV Partners |
| Date | Valuation | Stage |
|---|---|---|
| Aug 2010 | $124.91M | β’β’β’β’β’β’β’β’ |
Last known valuation $124.91M (Aug 2010). 2 investors in total: 2 institutional.
Investors in Quick Heal
Quick Heal has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Peak XV Partners and RippleWave.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in startups and providing support programs. | 2000 | peakxv.com | Bengaluru, India | |
Email and mail server services. | 2008 | ripplewave.net | Mumbai, India |
Investor details for Quick Heal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Quick Heal Technologies Limited (Quick Heal)
Quick Heal Technologies Limited is the primary company behind Quick Heal. The boards of the 2 registered companies of Quick Heal currently have 7 directors; the longest-serving is Kailash Sahebrao Katkar, appointed in 1995. 35 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kailash Sahebrao Katkar DIN 00397191 | Managing Director | 17 Aug 1995 | 31 yrs 2 mo | Quick Heal Technologies Limited |
| Sanjay Katkar Sahebrao DIN 00397277 | Managing Director | 17 Aug 1995 | 31 yrs 2 mo | Quick Heal Technologies Limited |
| Amitabha Mukhopadhyay DIN 01806781 | Director | 10 Jun 2019 | 7 yrs 5 mo | Quick Heal Technologies Limited |
| Kamal Kumar Agarwal DIN 02831435 | Director | 26 Jul 2024 | 2 yrs 3 mo | Quick Heal Technologies Limited |
| Pooja Parag Rathi DIN 07393897 | Designated Partner | 08 Jan 2025 | 1 yr 10 mo | Gagan Bharari Enterprises Llp |
| Amod Santosh Tirmanwar DIN 10898242 | Designated Partner | 08 Jan 2025 | 1 yr 10 mo | Gagan Bharari Enterprises Llp |
| Amita Shantanu Mirajkar DIN 06945253 | Director | 07 Aug 2025 | 1 yr 3 mo | Quick Heal Technologies Limited |
People of Quick Heal
142 people are tracked at Quick Heal (23 in leadership, 119 in team); the tracked headcount is 977.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
| Co-Founder & CTO | Leadership | |
Sourav Kar | Program Manager - Strategy - Ceo’s Office | Leadership |
Vishal Salvi | CEO | Leadership |
Sudhanshu Tripathi | Chief Marketing Officer & Head ESG | Leadership |
Sonal Raj | Marketing Director - Global Consumer Business | Leadership |
Ashish Pradhan | CTO | Leadership |
Swapna Sangari | VP, Human Resources | Leadership |
Dr. Lalit Mohan Sanagavarapu | Chief Product Officer | Leadership |
Shahid M. | Director Engineering | Leadership |
Swapna Sangarri | Vice President Human Resources | Leadership |
Souvik D. | Director Of Engineering - Enterprise & Retail Products (anti-virus, Anti-fraud, Emm) | Leadership |
Rehan A A | Western India Head | Leadership |
Deepak Mishra | Head, Retail Sales | Leadership |
Jaswinder Singh | Director Of Engineering | Leadership |
Ankit Maheshwari | Chief Financial Officer | Leadership |
Sneha Katkar | Head Of Product Strategy | Leadership |
Venu Gopal Dubey | Head Sales Business Development | Leadership |
Gitesh Patle | Director Finance | Leadership |
Navaneeth Krishnan Nadar | Head Presales | Leadership |
122 more people are available in the full profile.
Complete people profiles for Quick Heal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Quick Heal
Quick Heal is a publicly listed company on the NSE with ticker symbol QUICKHEAL in India, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Feb 2016
- Listed onNSE: QUICKHEAL · BSE: 539678
- Listed entityQuick Heal Technologies Ltd.
- Exchange sectorTechnology services
- ISININE306L01010
- Share price₹153.35 (+12.77% on the day) · 2026-10-14
- Market capitalisation₹738 Cr
- EPS (diluted, trailing year)₹-2.05
- Volume (last session)2,386,634
Financials of Quick Heal
Exchange-reported figures of Quick Heal Technologies Limited, the listed company behind Quick Heal (NSE: QUICKHEAL).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 261 | 280 | 292 | 278 | 342 | 333 | 286 |
| Revenue growth | -6.6% | -4.2% | +4.9% | -18.7% | +2.7% | +16.4% | - |
| EBITDA | (29.37) | (6.59) | 17.55 | 1.88 | 107 | 141 | 91.40 |
| EBITDA margin | -11.3% | -2.4% | +6.0% | +0.7% | +31.3% | +42.5% | +31.9% |
| Profit before tax | (20.64) | 1.00 | 26.21 | 8.02 | 109 | 146 | 101 |
| Net profit | (16.76) | 2.75 | 22.70 | 0.82 | 79.84 | 105 | 72.03 |
| Net profit margin | -6.4% | +1.0% | +7.8% | +0.3% | +23.4% | +31.4% | +25.2% |
| EPS (βΉ) | (2.02) | 0.93 | 4.53 | 1.21 | 14.34 | 16.66 | 11.59 |
| Balance sheet | |||||||
| Total assets | 439 | 443 | 439 | 421 | 629 | 752 | 646 |
| Net worth | 437 | 441 | 437 | 420 | 628 | 751 | 644 |
| Total debt | 0.11 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash & bank | 13.24 | 20.97 | 37.76 | 11.85 | 63.05 | 84.32 | 80.03 |
| Net working capital | 55.28 | 117 | 108 | 75.33 | 158 | 174 | 154 |
| Cash flow | |||||||
| Cash from operations | 15.39 | (22.29) | 18.19 | 30.81 | 79.98 | 98.62 | 70.56 |
| Cash from investing | (25.85) | 15.95 | 6.14 | 185 | 126 | (92.36) | 148 |
| Cash from financing | 2.76 | (10.33) | 1.60 | (212) | (214) | 0.10 | (221) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 64.93 | 44.99 | 48.73 | 71.54 | 83.52 | 57.23 | 65.14 | 70.61 |
| Revenue growth (YoY) | -22.3% | -21.4% | -25.2% | +1.3% | +13.7% | -18.6% | - | - |
| Other income | 8.34 | 14.10 | 3.75 | 8.95 | 4.38 | 5.75 | 5.60 | 4.91 |
| EBITDA | 2.30 | (17.57) | (29.32) | 0.45 | 9.23 | (9.73) | (8.48) | (3.77) |
| EBITDA margin | +3.5% | -39.1% | -60.2% | +0.6% | +11.1% | -17.0% | -13.0% | -5.3% |
| Depreciation | 5.78 | 3.85 | 4.07 | 3.59 | 3.28 | 2.96 | 3.63 | 3.39 |
| Interest | 0.53 | 0.00 | 0.03 | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 |
| Profit before tax | 4.33 | (7.32) | (29.67) | 5.75 | 10.28 | (7.00) | (6.57) | (2.31) |
| Tax | (1.47) | (2.04) | (9.73) | (0.86) | 2.37 | (1.49) | (3.32) | (2.42) |
| Net profit | 5.80 | (5.28) | (19.94) | 6.61 | 7.91 | (5.51) | (3.25) | 0.11 |
| EPS (βΉ) | 1.03 | (0.94) | (3.56) | 1.18 | 1.42 | (1.00) | (0.60) | 0.02 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 261 | 280 | 292 | 278 | 342 | 334 | 283 |
| Revenue growth | -6.6% | -4.2% | +4.9% | -18.6% | +2.4% | +17.7% | - |
| EBITDA | (28.73) | (6.01) | 17.40 | 2.80 | 102 | 141 | 90.76 |
| EBITDA margin | -11.0% | -2.2% | +6.0% | +1.0% | +29.8% | +42.4% | +32.0% |
| Profit before tax | (20.14) | 1.53 | 26.04 | 9.29 | 104 | 146 | 100 |
| Net profit | (16.26) | 3.28 | 22.29 | 1.80 | 77.86 | 105 | 72.86 |
| Net profit margin | -6.2% | +1.2% | +7.6% | +0.7% | +22.8% | +31.3% | +25.7% |
| EPS (βΉ) | (1.92) | 1.03 | 4.50 | 1.45 | 13.48 | 16.63 | 11.47 |
| Balance sheet | |||||||
| Total assets | 440 | 443 | 439 | 421 | 629 | 756 | 651 |
| Net worth | 437 | 442 | 437 | 420 | 627 | 756 | 648 |
| Total debt | 0.11 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash & bank | 12.07 | 17.23 | 36.71 | 10.56 | 59.20 | 77.39 | 73.51 |
| Net working capital | 55.19 | 116 | 107 | 74.52 | 155 | 166 | 148 |
| Cash flow | |||||||
| Cash from operations | 17.85 | (25.00) | 18.42 | 30.99 | 78.21 | 100 | 70.78 |
| Cash from investing | (25.74) | 15.97 | 6.15 | 188 | 130 | (94.46) | 146 |
| Cash from financing | 2.76 | (10.33) | 1.60 | (212) | (214) | 0.11 | (221) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 64.94 | 44.99 | 48.77 | 71.54 | 83.52 | 57.23 | 65.13 | 70.54 |
| Revenue growth (YoY) | -22.3% | -21.4% | -25.1% | +1.4% | +13.5% | -18.6% | - | - |
| Other income | 8.33 | 14.12 | 3.70 | 8.86 | 4.38 | 5.75 | 5.54 | 4.91 |
| Total expenses | 62.63 | 62.40 | 78.01 | 70.75 | 74.13 | 66.90 | 72.98 | 74.20 |
| EBITDA | 2.31 | (17.41) | (29.24) | 0.79 | 9.39 | (9.67) | (7.85) | (3.66) |
| EBITDA margin | +3.6% | -38.7% | -60.0% | +1.1% | +11.2% | -16.9% | -12.1% | -5.2% |
| Depreciation | 5.78 | 3.85 | 4.07 | 3.59 | 3.28 | 2.96 | 3.63 | 3.39 |
| Interest | 0.53 | 0.00 | 0.03 | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 |
| Profit before tax | 4.33 | (7.14) | (29.64) | 6.00 | 10.44 | (6.94) | (6.00) | (2.20) |
| Tax | (1.47) | (2.04) | (9.73) | (0.86) | 2.37 | (1.49) | (3.32) | (2.42) |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 64.93 | 44.99 | 48.73 | 71.54 | 83.52 | 57.23 | 65.14 | 70.61 |
| Revenue growth (YoY) | -22.3% | -21.4% | -25.2% | +1.3% | +13.7% | -18.6% | - | - |
| Other income | 8.34 | 14.10 | 3.75 | 8.95 | 4.38 | 5.75 | 5.60 | 4.91 |
| EBITDA | 2.30 | (17.57) | (29.32) | 0.45 | 9.23 | (9.73) | (8.48) | (3.77) |
| EBITDA margin | +3.5% | -39.1% | -60.2% | +0.6% | +11.1% | -17.0% | -13.0% | -5.3% |
| Depreciation | 5.78 | 3.85 | 4.07 | 3.59 | 3.28 | 2.96 | 3.63 | 3.39 |
| Interest | 0.53 | 0.00 | 0.03 | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 |
| Profit before tax | 4.33 | (7.32) | (29.67) | 5.75 | 10.28 | (7.00) | (6.57) | (2.31) |
| Tax | (1.47) | (2.04) | (9.73) | (0.86) | 2.37 | (1.49) | (3.32) | (2.42) |
| Net profit | 5.80 | (5.28) | (19.94) | 6.61 | 7.91 | (5.51) | (3.25) | 0.11 |
| EPS (βΉ) | 1.03 | (0.94) | (3.56) | 1.18 | 1.42 | (1.00) | (0.60) | 0.02 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 261 | 280 | 292 | 278 | 342 | 333 | 286 |
| Revenue growth | -6.6% | -4.2% | +4.9% | -18.7% | +2.7% | +16.4% | - |
| Other income | 22.83 | 20.77 | 21.39 | 22.13 | 19.20 | 24.16 | 31.60 |
| Total expenses | 290 | 286 | 274 | 276 | 235 | 192 | 195 |
| Employee cost | 183 | 186 | 169 | 155 | 139 | 115 | 101 |
| EBITDA | (29.37) | (6.59) | 17.55 | 1.88 | 107 | 141 | 91.40 |
| EBITDA margin | -11.3% | -2.4% | +6.0% | +0.7% | +31.3% | +42.5% | +31.9% |
| Depreciation | 13.90 | 12.96 | 12.60 | 15.99 | 17.38 | 19.49 | 21.68 |
| Interest | 0.20 | 0.22 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (20.64) | 1.00 | 26.21 | 8.02 | 109 | 146 | 101 |
| Tax | (9.71) | (4.04) | 1.97 | 1.62 | 25.49 | 39.16 | 26.90 |
| Net profit | (16.76) | 2.75 | 22.70 | 0.82 | 79.84 | 105 | 72.03 |
| Net profit margin | -6.4% | +1.0% | +7.8% | +0.3% | +23.4% | +31.4% | +25.2% |
| EPS (βΉ) | (2.02) | 0.93 | 4.53 | 1.21 | 14.34 | 16.66 | 11.59 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 54.24 | 54.00 | 53.51 | 53.07 | 58.01 | 64.21 | 64.20 |
| Reserves & surplus | 382 | 387 | 383 | 367 | 570 | 687 | 580 |
| Shareholders' funds (net worth) | 437 | 441 | 437 | 420 | 628 | 751 | 644 |
| Minority interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 0.11 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 0.11 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 439 | 443 | 439 | 421 | 629 | 752 | 646 |
| Assets | |||||||
| Gross block | 331 | 321 | 308 | 312 | 313 | 316 | 311 |
| Net block | 122 | 119 | 117 | 124 | 137 | 146 | 158 |
| Capital work in progress | 0.00 | 0.05 | 3.06 | 0.15 | 0.00 | 2.11 | 3.40 |
| Investments | 213 | 179 | 190 | 198 | 318 | 416 | 310 |
| Inventories | 2.59 | 2.22 | 2.80 | 4.50 | 4.79 | 3.34 | 6.24 |
| Sundry debtors | 138 | 167 | 132 | 123 | 172 | 151 | 113 |
| Cash & bank balances | 13.24 | 20.97 | 37.76 | 11.85 | 63.05 | 84.32 | 80.03 |
| Loans & advances | 10.04 | 9.19 | 9.02 | 8.27 | 4.75 | 9.89 | 4.71 |
| Total current assets | 163 | 199 | 181 | 147 | 245 | 248 | 204 |
| Total current liabilities | 108 | 82.48 | 73.30 | 71.94 | 86.20 | 74.02 | 50.07 |
| Net working capital | 55.28 | 117 | 108 | 75.33 | 158 | 174 | 154 |
| Total assets | 439 | 443 | 439 | 421 | 629 | 752 | 646 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 20.84 | 37.51 | 11.58 | 7.83 | 16.43 | 10.07 | 12.96 |
| Net cash from operating activities | 15.39 | (22.29) | 18.19 | 30.81 | 79.98 | 98.62 | 70.56 |
| Net cash from investing activities | (25.85) | 15.95 | 6.14 | 185 | 126 | (92.36) | 148 |
| Net cash from financing activities | 2.76 | (10.33) | 1.60 | (212) | (214) | 0.10 | (221) |
| Net change in cash | (7.70) | (16.67) | 25.93 | 3.75 | (8.60) | 6.36 | (2.88) |
| Closing cash | 13.24 | 20.97 | 37.76 | 11.85 | 63.05 | 84.32 | 80.03 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -6.6% | -4.2% | +4.9% | -18.7% | +2.7% | +16.4% | - |
| EBITDA growth | -345.7% | -137.6% | +833.5% | -98.2% | -24.5% | +54.8% | - |
| PBT growth | - | -96.2% | +226.8% | -92.6% | -25.6% | +44.2% | -26.1% |
| Net income growth | -709.5% | -87.9% | +2668.3% | -99.0% | -23.7% | +45.4% | - |
| Revenue CAGR (3Y) | -2.1% | -6.5% | -4.3% | -1.0% | +2.8% | +1.5% | -1.6% |
| EBITDA CAGR (3Y) | - | - | -50.1% | -72.6% | -5.8% | +5.5% | +1.9% |
| Profitability & leverage | |||||||
| Net income margin | -4.2% | +1.8% | +8.3% | +2.3% | +24.3% | +32.1% | +26.0% |
| Return on capital employed | -6.0% | -0.2% | +6.1% | +0.2% | +15.7% | +20.9% | +14.1% |
| Return on net worth | -3.8% | +0.6% | +5.7% | +0.2% | +12.1% | +15.3% | +10.4% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | -0.46 | -1.13 | 2.63 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.80 | 0.89 | 0.94 | 0.89 | 1.09 | 1.06 | 0.93 |
| Inventory turnover | 108.53 | 111.37 | 79.93 | 59.87 | 84.11 | 69.53 | 49.21 |
| Debtors turnover | 1.72 | 1.87 | 2.29 | 1.89 | 2.12 | 2.53 | 2.40 |
| EPS (βΉ) | (2.02) | 0.93 | 4.53 | 1.21 | 14.34 | 16.66 | 11.59 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 3.00 | 2.50 | 4.50 | 4.00 | 4.00 |
| Book value per share (βΉ) | 80.48 | 81.76 | 81.67 | 79.09 | 108.19 | 117.03 | 100.32 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 64.94 | 44.99 | 48.77 | 71.54 | 83.52 | 57.23 | 65.13 | 70.54 |
| Revenue growth (YoY) | -22.3% | -21.4% | -25.1% | +1.4% | +13.5% | -18.6% | - | - |
| Other income | 8.33 | 14.12 | 3.70 | 8.86 | 4.38 | 5.75 | 5.54 | 4.91 |
| Total expenses | 62.63 | 62.40 | 78.01 | 70.75 | 74.13 | 66.90 | 72.98 | 74.20 |
| EBITDA | 2.31 | (17.41) | (29.24) | 0.79 | 9.39 | (9.67) | (7.85) | (3.66) |
| EBITDA margin | +3.6% | -38.7% | -60.0% | +1.1% | +11.2% | -16.9% | -12.1% | -5.2% |
| Depreciation | 5.78 | 3.85 | 4.07 | 3.59 | 3.28 | 2.96 | 3.63 | 3.39 |
| Interest | 0.53 | 0.00 | 0.03 | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 |
| Profit before tax | 4.33 | (7.14) | (29.64) | 6.00 | 10.44 | (6.94) | (6.00) | (2.20) |
| Tax | (1.47) | (2.04) | (9.73) | (0.86) | 2.37 | (1.49) | (3.32) | (2.42) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 261 | 280 | 292 | 278 | 342 | 334 | 283 |
| Revenue growth | -6.6% | -4.2% | +4.9% | -18.6% | +2.4% | +17.7% | - |
| Other income | 22.69 | 20.72 | 21.37 | 22.48 | 19.17 | 23.94 | 31.34 |
| Total expenses | 290 | 286 | 274 | 275 | 240 | 192 | 193 |
| Employee cost | 182 | 185 | 169 | 155 | 138 | 113 | 99.99 |
| EBITDA | (28.73) | (6.01) | 17.40 | 2.80 | 102 | 141 | 90.76 |
| EBITDA margin | -11.0% | -2.2% | +6.0% | +1.0% | +29.8% | +42.4% | +32.0% |
| Depreciation | 13.90 | 12.96 | 12.60 | 15.99 | 17.38 | 19.48 | 21.66 |
| Interest | 0.20 | 0.22 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (20.14) | 1.53 | 26.04 | 9.29 | 104 | 146 | 100 |
| Tax | (9.71) | (4.04) | 1.97 | 1.59 | 25.37 | 39.04 | 26.81 |
| Net profit | (16.26) | 3.28 | 22.29 | 1.80 | 77.86 | 105 | 72.86 |
| Net profit margin | -6.2% | +1.2% | +7.6% | +0.7% | +22.8% | +31.3% | +25.7% |
| EPS (βΉ) | (1.92) | 1.03 | 4.50 | 1.45 | 13.48 | 16.63 | 11.47 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 54.24 | 54.00 | 53.51 | 53.07 | 58.01 | 64.21 | 64.20 |
| Reserves & surplus | 383 | 388 | 383 | 367 | 569 | 692 | 584 |
| Shareholders' funds (net worth) | 437 | 442 | 437 | 420 | 627 | 756 | 648 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 0.11 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 0.11 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total liabilities | 440 | 443 | 439 | 421 | 629 | 756 | 651 |
| Assets | |||||||
| Gross block | 330 | 321 | 308 | 312 | 313 | 316 | 311 |
| Net block | 122 | 119 | 117 | 124 | 137 | 146 | 158 |
| Capital work in progress | 0.00 | 0.05 | 3.06 | 0.15 | 0.00 | 2.11 | 3.40 |
| Investments | 214 | 180 | 191 | 198 | 321 | 428 | 320 |
| Inventories | 2.59 | 2.22 | 2.80 | 4.50 | 4.79 | 3.29 | 6.22 |
| Sundry debtors | 140 | 170 | 132 | 123 | 173 | 149 | 113 |
| Cash & bank balances | 12.07 | 17.23 | 36.71 | 10.56 | 59.20 | 77.39 | 73.51 |
| Loans & advances | 9.96 | 9.12 | 8.91 | 8.21 | 4.68 | 9.73 | 4.58 |
| Total current assets | 165 | 199 | 180 | 146 | 242 | 240 | 198 |
| Total current liabilities | 109 | 82.75 | 73.38 | 71.52 | 86.63 | 73.56 | 49.35 |
| Net working capital | 55.19 | 116 | 107 | 74.52 | 155 | 166 | 148 |
| Total assets | 440 | 443 | 439 | 421 | 629 | 756 | 651 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 17.10 | 36.46 | 10.29 | 3.97 | 9.50 | 3.56 | 7.96 |
| Net cash from operating activities | 17.85 | (25.00) | 18.42 | 30.99 | 78.21 | 100 | 70.78 |
| Net cash from investing activities | (25.74) | 15.97 | 6.15 | 188 | 130 | (94.46) | 146 |
| Net cash from financing activities | 2.76 | (10.33) | 1.60 | (212) | (214) | 0.11 | (221) |
| Net change in cash | (5.13) | (19.36) | 26.17 | 6.32 | (5.53) | 5.94 | (4.41) |
| Closing cash | 12.07 | 17.23 | 36.71 | 10.56 | 59.20 | 77.39 | 73.51 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -6.6% | -4.2% | +4.9% | -18.6% | +2.4% | +17.7% | - |
| EBITDA growth | -378.0% | -134.5% | +521.4% | -97.3% | -28.0% | +55.8% | - |
| PBT growth | - | -94.1% | +180.3% | -91.0% | -29.0% | +45.2% | -22.2% |
| Net income growth | -595.7% | -85.3% | +1138.3% | -97.7% | -25.5% | +43.4% | - |
| Revenue CAGR (3Y) | -2.1% | -6.5% | -4.4% | -0.6% | +3.0% | +1.8% | -1.8% |
| EBITDA CAGR (3Y) | - | - | -50.3% | -68.6% | -5.4% | +6.8% | -0.8% |
| Profitability & leverage | |||||||
| Net income margin | -4.0% | +2.0% | +8.3% | +2.8% | +22.9% | +32.0% | +26.0% |
| Return on capital employed | -5.8% | -0.1% | +6.1% | +0.4% | +15.0% | +20.7% | +13.9% |
| Return on net worth | -3.7% | +0.8% | +5.6% | +0.3% | +11.3% | +15.2% | +10.2% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | -0.47 | -1.16 | 2.71 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.80 | 0.89 | 0.94 | 0.89 | 1.09 | 1.06 | 0.92 |
| Inventory turnover | 108.55 | 111.37 | 79.93 | 59.87 | 84.54 | 70.14 | 54.71 |
| Debtors turnover | 1.68 | 1.85 | 2.29 | 1.88 | 2.12 | 2.54 | 2.38 |
| EPS (βΉ) | (1.92) | 1.03 | 4.50 | 1.45 | 13.48 | 16.63 | 11.47 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 3.00 | 2.50 | 4.50 | 4.00 | 4.00 |
| Book value per share (βΉ) | 80.61 | 81.82 | 81.65 | 79.09 | 108.12 | 117.71 | 100.96 |
Investments & Acquisitions by Quick Heal
Quick Heal has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Junco Technologies.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
IT security consulting and services are offered to enterprises. | juncotech.com | Pune, India | 2014 | Jun 2016 | β’β’β’β’ |
Complete acquisition details for Quick Heal
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Quick Heal
5 dated milestones of Quick Heal across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Quick Heal is founded.
- Funding First funding round of $8.3M.
- Milestone Reaches Minicorn status.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Junco Technologies.
Web traffic of Quick Heal
The website of Quick Heal (quickheal.co.in) receives about 501.6K visits a month and ranks #107,677 among all websites worldwide, #832 in Search Engines.
- Monthly visits501.6K
▲ 4% vs previous month
- Unique visitors276.1K
per month
- Global rank#107,677
among all websites
- Category rank#832
Computers Electronics and Technology · Search Engines
- Bounce rate45%
- Pages per visit2.3
- Average visit2 min 09 sec
- DevicesDesktop 72% Β· Mobile 28%
Websites whose visitors overlap most with Quick Heal. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| kaspersky.co.in | 100% | 309.6K | #153,567 | View details | |
| avast.com | 74% | 12.7M | #4,813 | View details | |
| justdial.com | 67% | 91.3M | #480 | View details | |
music.youtube.com | music.youtube.com | 62% | #72 | β | |
| eset.com | 62% | 6M | #6,641 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Quick Heal
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Quick Heal
Complete news archive for Quick Heal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quick Heal
Quick Heal was founded in 1995 and raised its 1st funding round 15 years after it was founded.
Quick Heal is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Kailash Katkar is the CEO of Quick Heal, as recorded in our data. They have also founded this company.
Quick Heal has 977 employees.
The primary company behind Quick Heal, Quick Heal Technologies Limited, reported revenue of βΉ284 Cr for FY 2026, down 7% year on year.
Quick Heal was founded in 1995 in Pune, India, within the cybersecurity sector. A cloud-based platform is operated to provide endpoint security through antivirus solutions for PCs, laptops, Macs, and Windows devices. Protection from cyber attacks and threats is ensured, supporting device performance and user security across operations.
Yes, Quick Heal is publicly traded on NSE under the ticker symbol QUICKHEAL.
Quick Heal has made 1 acquisition, including Junco Technologies.
Quick Heal has 2 investors. Key investors include Peak XV Partners, and RippleWave.
The valuation of Quick Heal is $124.91M as of Aug 2010.
Quick Heal is associated with 2 legal entities: Quick Heal Technologies Limited, Gagan Bharari Enterprises Llp.
The legal entities of Quick Heal currently have 10 directors, including Pooja Parag Rathi, Amod Santosh Tirmanwar, Kailash Sahebrao Katkar and others.
